Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Waters

Profile and portfolio

Parent WatersHQ Milford, United States

This profile covers the startup investments made by Waters, a healthcare company. It is based in Milford, United States. It invests from Series A to Series C+. Sectors it names: biotech and life sciences.

Every figure links to its source

Snapshot

Investment stage: Series A to Series C+
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeries A to Series C+
SectorsBiotech and life sciences
GeographyNorth America
OfficesMilford, United States

Sources: S1 PRWeb: RedShift BioAnalytics completes USD 11.0 million Series C (2017-03-14).

Graphic 1 of 1

Investment stage: Series A to Series C+

Sources: S1 PRWeb: RedShift BioAnalytics completes USD 11.0 million Series C (2017-03-14).

Download:Report a correction

Where it invests

Geography

Headquarters
Milford, United States
Offices
  • Milford, United States

Investment regionsS1

Key facts

FactValueStatusSource
Parent companyWaters (NYSE: WAT)Single sourceS5
Parent industryHealthcare and life sciencesSingle sourceS5
HeadquartersMilford, United StatesSingle sourceS5
StatusActiveSingle sourceS1
Capital sourceParent company onlySingle sourceS1
StagesSeries A, Series B, Series C+ (inferred from announced rounds)EstimateS1

About Waters

ItemDetailSource
Listed asNYSE: WATS5
HeadquartersUnited StatesS5

Recent rounds

DateCompanyRoundAmountLed by the firmSource
2019-05-29RiffynSeries BUSD 15MNoS2
2017-03-14RedShift BioAnalyticsSeries C+USD 11MYesS1

Portfolio

Public sources name 3 portfolio companies.S1

Shared portfolio with other corporate VCs

1 companies on the Waters portfolio page also appear on the portfolio page of at least one other firm in this directory. Matched by company website, or by name where no website is published.

FirmSharedCompanies in common
Holtzbrinck Digital1TetraScience

Companies backed by the most corporate VCs

Every company on the Waters list

3 companies, as named in the sources cited.S1 Read the firm's list.

  • RedShift BioAnalytics
  • Riffyn
  • TetraScience

Official pages

Read the firm's own pages for current information.

Sources

  1. S1PRWeb: RedShift BioAnalytics completes USD 11.0 million Series C (2017-03-14)Portfolio company
  2. S2M Ventures: Riffyn raises USD 15M Series B (2019-05-29)Press
  3. S3PR Newswire: TetraScience secures investment from Waters in its USD 8M Series APortfolio company
  4. S5SEC EDGAR company page: Waters Corp (business address)Filing

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Waters or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.